Comparative Effectiveness of Particulate Versus Nonparticulate Steroid Injections for Musculoskeletal Conditions
Osteoarthritis, Tendinopathy, Impingement Shoulder
About this trial
This is an interventional treatment trial for Osteoarthritis focused on measuring corticosteroid injection, particulate steroid, non-particulate steroid
Eligibility Criteria
Inclusion Criteria:
- Age greater than or equal to 18
- Ability to provide informed consent
- Capable of complying with the outcome instruments used
- Capable of attending all planned follow up visits
- Patient is deemed appropriate for intra-articular hip, glenohumeral, peri-tendinous biceps, or subdeltoid bursa corticosteroid injection by their treating physician for the treatment of painful musculoskeletal condition
- Average pain of greater than or equal to 4/10 over the last 7 days
Exclusion Criteria:
- Unclear diagnosis
- Pregnancy
- Incarcerated patients
- Prior corticosteroid injection into the same anatomical site within the last 3 months
- Prior prosthetic surgery on the joint
- Any condition that increases injection risk such as bleeding tendencies, uncontrolled diabetes, current active infection, or infection requiring antibiotics within the last 7 days
- Chronic opioid use to control pain
- Workers compensation and litigation
- BMI > 40
Sites / Locations
- Stanford UniversityRecruiting
Arms of the Study
Arm 1
Arm 2
Other
Other
Particulate Corticosteroid Injection
Non-particulate Corticosteroid Injection
Intra-articular, peri-tendinous, or intra-bursal corticosteroid injection using 10-80mg of triamcinolone or 3-9mg of betamethasone depending on anatomical structure. Injections may be repeated up to 3 times in the 6 month study period based on physician discretion.
Intra-articular, peri-tendinous, or intra-bursal corticosteroid injection using 4-10mg of dexamethasone depending on anatomical structure. Injections may be repeated up to 3 times in the 6 month study period based on physician discretion.